Company Profile
National Research Corporation Stock Price, News & Analysis
- Ticker:
- NRC
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
19.47 USD (-0.36%)
Close
Last updated: August 6, 2026
441M USD
Market cap
Why the stock is moving
As of Aug 6, 2026, NRC closed down 0.36% at $19.47. No new same-company headline was identified in the current news window.
Company overview
Business overview
National Research Corporation is a healthcare analytics and experience company focused on measuring and improving patient, employee, and consumer outcomes. Its business is centered on data and analytics rather than biotech.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, National Research sits in healthcare information services.
Business Model Characteristics
The company generates revenue through software, analytics, and subscription-based measurement tools for healthcare organizations.
Position Within the Biotechnology Landscape
National Research is outside biotech and belongs to the healthcare-data layer where software adoption matters most.
Future catalysts
National Research Corporation's catalysts are subscription renewals, healthcare-analytics demand, and whether the patient-experience platform keeps its recurring revenue profile intact. A stable renewal picture would help confirm the business is still behaving like a durable software franchise.
Recent news
- 01
National Research Corporation Declares Quarterly Dividend
Source: National Research Corporation
- 02
National Research Corporation Announces Third Quarter 2023 Results
Source: National Research Corporation
- 03
National Research Corporation to Broadcast its 2023 Third Quarter Conference Call Live on the Internet
Source: National Research Corporation
- 04
Lurie Children’s expands partnership with NRC Health to gain valuable consumer insights
Source: National Research Corporation
- 05
National Research Corporation Declares Special Dividend
Source: National Research Corporation
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of National Research Corporation (NRC)?
National Research Corporation (NRC) most recently closed at 19.47 USD, a -0.36% move versus the previous session.
What is the market cap of National Research Corporation (NRC)?
National Research Corporation currently has a market capitalization of 441M USD on BioPharmSignal.
What does National Research Corporation do?
National Research Corporation is a healthcare analytics and experience company focused on measuring and improving patient, employee, and consumer outcomes. Its business is centered on data and analytics rather than biotech.
On which exchange is NRC stock listed?
National Research Corporation (NRC) is associated with NASDAQ, United States, Biopharma.
What is National?
National Research Corporation's catalysts are subscription renewals, healthcare-analytics demand, and whether the patient-experience platform keeps its recurring revenue profile intact.
Which conditions is National Research Corporation targeting with National?
National Research Corporation's catalysts are subscription renewals, healthcare-analytics demand, and whether the patient-experience platform keeps its recurring revenue profile intact.
How does National Research Corporation describe recent progress with National?
National Research Corporation's catalysts are subscription renewals, healthcare-analytics demand, and whether the patient-experience platform keeps its recurring revenue profile intact.
What is Research?
National Research Corporation is a healthcare analytics and experience company focused on measuring and improving patient, employee, and consumer outcomes.